GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,057,492 | +25.1% | 11,038,419 | +50.1% | 0.02% | +33.3% |
| Q2 2023 | $437,965,402 | +3.0% | 7,355,818 | -2.0% | 0.01% | -7.7% |
| Q1 2023 | $425,282,574 | -23.4% | 7,508,520 | +0.5% | 0.01% | -23.5% |
| Q4 2022 | $555,147,008 | +28.4% | 7,474,714 | +3.0% | 0.02% | +13.3% |
| Q3 2022 | $432,241,000 | +3.3% | 7,256,005 | -2.7% | 0.02% | +15.4% |
| Q2 2022 | $418,547,000 | -22.8% | 7,455,417 | +1.5% | 0.01% | -13.3% |
| Q1 2022 | $542,124,000 | +2.9% | 7,347,858 | +0.7% | 0.02% | +15.4% |
| Q4 2021 | $526,982,000 | -5.8% | 7,298,945 | -0.0% | 0.01% | -18.8% |
| Q3 2021 | $559,362,000 | -1.8% | 7,300,466 | -0.6% | 0.02% | 0.0% |
| Q2 2021 | $569,496,000 | +22.1% | 7,345,499 | -2.9% | 0.02% | +14.3% |
| Q1 2021 | $466,342,000 | -3.5% | 7,561,883 | +2.1% | 0.01% | -6.7% |
| Q4 2020 | $483,013,000 | +35.4% | 7,405,902 | +2.8% | 0.02% | +15.4% |
| Q3 2020 | $356,622,000 | -1.3% | 7,201,581 | -4.9% | 0.01% | -7.1% |
| Q2 2020 | $361,282,000 | -10.0% | 7,572,497 | -19.8% | 0.01% | -30.0% |
| Q1 2020 | $401,646,000 | -29.1% | 9,443,830 | -1.8% | 0.02% | -9.1% |
| Q4 2019 | $566,256,000 | +17.8% | 9,617,133 | +2.3% | 0.02% | +10.0% |
| Q3 2019 | $480,615,000 | +18.0% | 9,401,695 | -2.4% | 0.02% | +17.6% |
| Q2 2019 | $407,340,000 | -13.6% | 9,629,795 | +0.9% | 0.02% | -19.0% |
| Q1 2019 | $471,410,000 | +14.5% | 9,540,773 | +0.3% | 0.02% | 0.0% |
| Q4 2018 | $411,756,000 | -23.3% | 9,513,779 | +0.6% | 0.02% | -8.7% |
| Q3 2018 | $536,739,000 | +15.6% | 9,456,276 | +2.8% | 0.02% | +9.5% |
| Q2 2018 | $464,318,000 | +16.3% | 9,201,726 | +14.9% | 0.02% | +10.5% |
| Q1 2018 | $399,110,000 | +24.5% | 8,011,045 | +2.7% | 0.02% | +26.7% |
| Q4 2017 | $320,565,000 | +41.2% | 7,799,617 | +2.1% | 0.02% | +36.4% |
| Q3 2017 | $227,051,000 | -8.0% | 7,639,654 | +2.6% | 0.01% | -15.4% |
| Q2 2017 | $246,914,000 | +12.8% | 7,448,420 | +0.8% | 0.01% | +8.3% |
| Q1 2017 | $218,812,000 | +27423.5% | 7,387,282 | +22983.1% | 0.01% | +1100.0% |
| Q4 2016 | $795,000 | +412.9% | 32,003 | +365.6% | 0.00% | – |
| Q3 2016 | $155,000 | +6.2% | 6,874 | +12.2% | 0.00% | – |
| Q2 2016 | $146,000 | +22.7% | 6,127 | +22.6% | 0.00% | – |
| Q1 2016 | $119,000 | +112.5% | 4,998 | +146.4% | 0.00% | – |
| Q4 2015 | $56,000 | +60.0% | 2,028 | +19.2% | 0.00% | – |
| Q3 2015 | $35,000 | -20.5% | 1,701 | 0.0% | 0.00% | – |
| Q2 2015 | $44,000 | -2.2% | 1,701 | -4.8% | 0.00% | – |
| Q1 2015 | $45,000 | +7.1% | 1,786 | 0.0% | 0.00% | – |
| Q4 2014 | $42,000 | +20.0% | 1,786 | 0.0% | 0.00% | – |
| Q3 2014 | $35,000 | -16.7% | 1,786 | 0.0% | 0.00% | – |
| Q2 2014 | $42,000 | +13.5% | 1,786 | +29.7% | 0.00% | – |
| Q1 2014 | $37,000 | +32.1% | 1,377 | 0.0% | 0.00% | – |
| Q4 2013 | $28,000 | +12.0% | 1,377 | -5.7% | 0.00% | – |
| Q3 2013 | $25,000 | +8.7% | 1,460 | +8.2% | 0.00% | – |
| Q2 2013 | $23,000 | – | 1,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |